Search

Your search keyword '"Le May M."' showing total 193 results

Search Constraints

Start Over You searched for: Author "Le May M." Remove constraint Author: "Le May M."
193 results on '"Le May M."'

Search Results

2. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

3. ANTITHROMBOTIC THERAPIES IN CANADIAN ATRIAL FIBRILLATION PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEASE: INSIGHTS FROM THE CONNECT AF+PCI-I AND -II PROGRAMS

4. Outcomes of patients with high bleeding risks characteristics presenting with acute coronary syndrome undergoing percutaneous coronary intervention

5. OFF-HOURS PRESENTATION AND CLINICAL OUTCOMES IN PATIENTS TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: ANALYSIS OF THE UNIVERSITY OF OTTAWA HEART INSTITUTE REGISTRY

6. Comparing clinical outcomes following 1 year of dual antiplatelet therapy in patients risk stratified by the PRECISE-DAPT and DAPT scores

7. Do the results of the SYNTAX trial apply to my centre?

8. OUTCOMES OF APPROPRIATE VERSUS INAPPROPRIATE DE-ESCALATION OF P2Y12 INHIBITOR THERAPY POST PERCUTANEOUS CORONARY INTERVENTION: A RETROSPECTIVE COHORT STUDY.

13. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

14. APPROPRIATE VERSES INAPPROPRIATE DE-ESCALATION OF P2Y12 INHIBITOR THERAPY POST PERCUTANEOUS CORONARY INTERVENTION: A RETROSPECTIVE COHORT STUDY

15. INCIDENCE AND RATIONALE FOR P2Y12 INHIBITOR SWITCHING IN PATIENTS WITHIN 1 YEAR OF PERCUTANEOUS CORONARY INTERVENTION

16. DO THE DAPT AND PRECISE-DAPT SCORES PROVIDE CONCORDANT RECOMMENDATIONS FOR DURATION OF P2Y12 INHIBITOR TREATMENT AFTER PERCUTANEOUS CORONARY INTERVENTION?

17. MULTIDISCIPLINARY SHOCK TEAM APPROACH TO MANAGEMENT OF CARDIOGENIC SHOCK

22. DOES RENAL FUNCTION AFFECT THE EFFICACY OF PHARMACOINVASIVE STRATEGY IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION? A PATIENT LEVEL META-ANALYSIS

24. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

25. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study

28. BIVALIRUDIN FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH CARDIOGENIC SHOCK: OUTCOME ASSESSMENT IN THE CAPITAL STEMI REGISTRY

44. 332 Genetic testing for cyp2c19*2 but not for pon-1 qq carrier status predicts high on-clopidogrel platelet reactivity in patients undergoing percutaneous coronary interventions

45. 392 Mortality benefit associated with direct transfer from the field for primary PCI in ST-elevation myocardial infarction

49. Diagnosis of Cranial Asymmetries in Cerebral Arteriovenous Malformations

50. The Early Radiological Diagnosis of Osteomalacia in Adults

Catalog

Books, media, physical & digital resources